PMID- 35464038 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220429 IS - 2296-861X (Print) IS - 2296-861X (Electronic) IS - 2296-861X (Linking) VI - 9 DP - 2022 TI - Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia. PG - 873900 LID - 10.3389/fnut.2022.873900 [doi] LID - 873900 AB - BACKGROUND: Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens. OBJECTIVE: The goal of this study was to determine the levels of folate, vitamin B12, and homocysteine in the blood of women who had a pregnancy impacted by NTDs. SUBJECTS AND METHODS: A hospital-based case-control study was undertaken between September 2019 and August 2020. The study comprised a total of 100 cases and 167 controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of folate, vitamin B12, and homocysteine in the serum. RESULTS: Only 39% of the cases and 54.5% of control mothers reported periconceptional use of folic acid/multivitamin, which indicated a statistically significant difference (p = 0.014). Logistic regression indicated that periconceptional use of folic acid/multivitamin was associated with NTDs (p = 0.015, OR = 1.873, 95% CI: 1.131-3.101). We found that 57% of the cases and 33.5% of controls, as well as 43% of cases and 20.4% of controls had serum folate and vitamin B12 levels below the cut-off value, respectively. Twenty-seven percent of the cases and 6.6% of controls had hyperhomocysteinemia (HHcy). The median concentrations of folate, vitamin B12, and homocysteine in cases and controls were 4.78 and 8.86 ng/ml; 266.23 and 455 pg/ml; 13.43 and 9.7 mumol/l, respectively. The median concentration of folate (p < 0.001) and vitamin B12 (p < 0.001) were significantly lower in the cases than controls, while the homocysteine concentration (p < 0.001) was significantly lower in the controls than cases. Folate [OR (95% CI) = 1.652 (1.226-2.225; p = 0.001)], vitamin B12 [OR (95% CI) = 1.890 (1.393-2.565; p < 0.001], and homocysteine [OR (95% CI) = 0.191 (0.09-0.405; p < 0.001)] levels were associated with NTDs. CONCLUSION: Folate and vitamin B12 are deficient in both cases and control mothers. The lower levels of folate and vitamin B12 with an elevated homocysteine level in NTD-affected pregnancy may be an indication that these biochemical variables were risk factors for NTDs. Folate/multivitamin supplementation and/or food fortification should be promoted. CI - Copyright (c) 2022 Kucha, Seifu, Tirsit, Yigeremu, Abebe, Hailu, Tsehay and Genet. FAU - Kucha, Winner AU - Kucha W AD - Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. FAU - Seifu, Daniel AU - Seifu D AD - Biochemistry Division of Basic Sciences, University of Global Health Equity, Kigali, Rwanda. FAU - Tirsit, Abenezer AU - Tirsit A AD - Neurosurgery Unit, School of Medicine, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia. FAU - Yigeremu, Mahlet AU - Yigeremu M AD - Department of Obstetrics and Gynecology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. FAU - Abebe, Markos AU - Abebe M AD - Armauer Hansen Research Institute, Addis Ababa, Ethiopia. FAU - Hailu, Dawit AU - Hailu D AD - Armauer Hansen Research Institute, Addis Ababa, Ethiopia. FAU - Tsehay, Dareskedar AU - Tsehay D AD - Armauer Hansen Research Institute, Addis Ababa, Ethiopia. FAU - Genet, Solomon AU - Genet S AD - Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. LA - eng PT - Journal Article DEP - 20220408 PL - Switzerland TA - Front Nutr JT - Frontiers in nutrition JID - 101642264 PMC - PMC9033285 OTO - NOTNLM OT - ELISA OT - NTDs OT - folate OT - homocysteine OT - vitamin B12 COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/04/26 06:00 MHDA- 2022/04/26 06:01 PMCR- 2022/01/01 CRDT- 2022/04/25 05:27 PHST- 2022/02/11 00:00 [received] PHST- 2022/03/08 00:00 [accepted] PHST- 2022/04/25 05:27 [entrez] PHST- 2022/04/26 06:00 [pubmed] PHST- 2022/04/26 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fnut.2022.873900 [doi] PST - epublish SO - Front Nutr. 2022 Apr 8;9:873900. doi: 10.3389/fnut.2022.873900. eCollection 2022.